PriceSensitive

Creso Pharma (ASX:CPH) eyes entrance to Taiwanese animal healthcare market

ASX News, Health Care
ASX:CPH
30 June 2022 14:06 (AEST)

This browser does not support the video element.

Creso Pharma (CPH) has progressed activities to introduce Sierra Sage Herbs (SSH) products to the Taiwanese animal healthcare market.

The company secured a non-binding, non-exclusive Heads of Agreement (HoA) with China Chemical & Pharmaceutical (CCPC), which will establish an in-country partner to drive sales growth.

CCPC is focused on the research and development and manufacturing of pharmaceutical and healthcare products for use in animals and humans.

It has a dedicated animal healthcare team that works with veterinarians throughout Taiwan and is considered to be a highly trusted provider.

The initial focus of the agreement will be on the company’s Green Goo Animal First Aid product, which helps soothe and repair minor wounds.

However, the HoA provides the scope to expand the range of products the companies collaborate on.

Creso Pharma CEO and Managing Director William Lay said he’s delighted to be working with CCPC to develop a brand new market for CPH’s animal care products.

“We view this development as a testament to the broader opportunity we see for the Green
Goo range in other international markets,” Mr Lay said.

The companies have been working to establish a collaborative agreement before the end of August, which will set out the terms for commercialisation and select products from SSH’s pet care product range.

Shares were trading steady at 3.6 cents each at 2:05 pm AEST.

Related News